Indomethacin inhibition of pristane plasmacytomagenesis in genetically susceptible inbred mice.
Potter
M
M
Laboratory of Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology*; D002273:Carcinogens / Q000633:toxicity*; D003106:Colon / Q000187:drug effects; D007213:Indomethacin / Q000494:pharmacology*; D051379:Mice; D008807:Mice, Inbred BALB C; D010534:Peritoneal Neoplasms / Q000139:chemically induced / Q000235:genetics / Q000517:prevention & control; D010954:Plasmacytoma / Q000139:chemically induced* / Q000235:genetics / Q000517:prevention & control*; D011453:Prostaglandins / Q000096:biosynthesis; D017382:Reactive Oxygen Species / Q000378:metabolism; D013467:Sulindac / Q000494:pharmacology; D013729:Terpenes / Q000633:toxicity*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D002273:Carcinogens; D011453:Prostaglandins; D017382:Reactive Oxygen Species; D013729:Terpenes; D013467:Sulindac; C009042:pristane; D007213:Indomethacin